中商官网
研究报告
九典制药（300705）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 241000000.0000 | 24141400.0000 | 28990100.0000 | 25266900.0000 | 252000000.0000 | 76302100.0000 | 176000000.0000 |
| 2014 | 266000000.0000 | 40399800.0000 | 43590200.0000 | 37786700.0000 | 269000000.0000 | 58707200.0000 | 210000000.0000 |
| 2015 | 290000000.0000 | 45491400.0000 | 49525200.0000 | 44642800.0000 | 318000000.0000 | 63810800.0000 | 255000000.0000 |
| 2016 | 376000000.0000 | 60819500.0000 | 62655500.0000 | 54527300.0000 | 397000000.0000 | 73604600.0000 | 323000000.0000 |
| 2017 | 535000000.0000 | 74839600.0000 | 77018400.0000 | 68573400.0000 | 769000000.0000 | 109000000.0000 | 660000000.0000 |
| 2018 | 801000000.0000 | 80248100.0000 | 79405300.0000 | 71985000.0000 | 943000000.0000 | 225000000.0000 | 718000000.0000 |
| 2019 | 924000000.0000 | 62895900.0000 | 58898000.0000 | 55065900.0000 | 1072000000.0000 | 310000000.0000 | 762000000.0000 |
| 2020 | 978000000.0000 | 91719600.0000 | 90840700.0000 | 82259800.0000 | 1131000000.0000 | 295000000.0000 | 836000000.0000 |
| 2021 | 1628000000.0000 | 226000000.0000 | 226000000.0000 | 204000000.0000 | 1745000000.0000 | 646000000.0000 | 1099000000.0000 |
| 2022 | 2326000000.0000 | 291000000.0000 | 290000000.0000 | 270000000.0000 | 2300000000.0000 | 747000000.0000 | 1553000000.0000 |
| 2023 | 2693000000.0000 | 394000000.0000 | 402000000.0000 | 368000000.0000 | 2871000000.0000 | 898000000.0000 | 1973000000.0000 |
| 2024 | 2931000000.0000 | 575000000.0000 | 572000000.0000 | 512000000.0000 | 3373000000.0000 | 846000000.0000 | 2527000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 9.96 | 12.03 | 11.50 | 18.7000 | 2.0700 | 7.06 | 0.96 |
| 2014 | 14.66 | 16.39 | 16.20 | 19.4300 | 2.3700 | 8.12 | 0.99 |
| 2015 | 15.52 | 17.08 | 15.57 | 19.2300 | 2.3500 | 7.59 | 0.91 |
| 2016 | 15.96 | 16.66 | 15.78 | 17.9300 | 2.5900 | 7.75 | 0.95 |
| 2017 | 13.46 | 14.40 | 10.02 | 16.1400 | 2.9600 | 7.98 | 0.70 |
| 2018 | 9.24 | 9.91 | 8.42 | 10.4600 | 3.1600 | 8.29 | 0.85 |
| 2019 | 5.30 | 6.37 | 5.49 | 7.4500 | 2.4500 | 7.62 | 0.86 |
| 2020 | 7.46 | 9.29 | 8.03 | 10.3100 | 1.7000 | 6.63 | 0.86 |
| 2021 | 12.16 | 13.88 | 12.95 | 20.8800 | 1.9000 | 7.88 | 0.93 |
| 2022 | 11.35 | 12.47 | 12.61 | 18.6000 | 2.2700 | 6.58 | 1.01 |
| 2023 | 13.52 | 14.93 | 14.00 | 21.2200 | 2.4300 | 5.37 | 0.94 |
| 2024 | 17.74 | 19.52 | 16.96 | 23.2700 | 2.4800 | 6.54 | 0.87 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 30.28 | 69.84 | 1.9800 | 1.2000 |
| 2014 | 21.82 | 78.07 | 2.5700 | 1.4000 |
| 2015 | 20.07 | 80.19 | 2.9200 | 1.7600 |
| 2016 | 18.54 | 81.36 | 3.2500 | 2.0600 |
| 2017 | 14.17 | 85.83 | 6.4900 | 5.2400 |
| 2018 | 23.86 | 76.14 | 2.9700 | 2.0700 |
| 2019 | 28.92 | 71.08 | 2.2600 | 1.4000 |
| 2020 | 26.08 | 73.92 | 2.7800 | 1.8000 |
| 2021 | 37.02 | 62.98 | 2.7500 | 2.1200 |
| 2022 | 32.48 | 67.52 | 2.7200 | 2.1200 |
| 2023 | 31.28 | 68.72 | 3.4400 | 2.7500 |
| 2024 | 25.08 | 74.92 | 4.0900 | 3.0100 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 217000000.0000 | 58075800.0000 | 45704900.0000 | 2348200.0000 |
| 2014 | 227000000.0000 | 57879100.0000 | 35223000.0000 | 1290500.0000 |
| 2015 | 245000000.0000 | 61206400.0000 | 39602400.0000 | 922900.0000 |
| 2016 | 316000000.0000 | 92770500.0000 | 34709700.0000 | 1329000.0000 |
| 2017 | 463000000.0000 | 142000000.0000 | 26181000.0000 | 676700.0000 |
| 2018 | 727000000.0000 | 305000000.0000 | 29148700.0000 | 1294200.0000 |
| 2019 | 875000000.0000 | 409000000.0000 | 35728200.0000 | 4676300.0000 |
| 2020 | 905000000.0000 | 509000000.0000 | 38231500.0000 | 5249100.0000 |
| 2021 | 1430000000.0000 | 832000000.0000 | 46203100.0000 | 16145400.0000 |
| 2022 | 2062000000.0000 | 1220000000.0000 | 65320100.0000 | 18691500.0000 |
| 2023 | 2329000000.0000 | 1307000000.0000 | 97988000.0000 | 11480800.0000 |
| 2024 | 2411000000.0000 | 1239000000.0000 | 92286400.0000 | 18856400.0000 |